Regeneron Pharmaceuticals REGN TD Cowen Ups Price Target Ahead of Fiscal Q1 Results Supported by FDA Gene Therapy Approval Is Dare Bio DARE stock gaining momentum Q4 2025 EPS Beats Forecasts Is Olenox Industries OLOX stock a smart investment Q3 2023 EPS Exceeds Expectations